Walleye Capital LLC Neogenomics Inc Transaction History
Walleye Capital LLC
- $38.9 Billion
- Q4 2024
A detailed history of Walleye Capital LLC transactions in Neogenomics Inc stock. As of the latest transaction made, Walleye Capital LLC holds 31,800 shares of NEO stock, worth $313,548. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,800
Previous 22,300
42.6%
Holding current value
$313,548
Previous $328,000
59.76%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding NEO
# of Institutions
282Shares Held
124MCall Options Held
751KPut Options Held
107K-
Black Rock Inc. New York, NY19.7MShares$194 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.2MShares$140 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.53MShares$64.4 Million0.07% of portfolio
-
Janus Henderson Group PLC London, X06.17MShares$60.8 Million0.05% of portfolio
-
Brown Advisory Inc6.16MShares$60.7 Million0.13% of portfolio
About NEOGENOMICS INC
- Ticker NEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 125,796,000
- Market Cap $1.24B
- Description
- NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...